Quantitative Analysis Challenges for GLP-1 Peptides

Having covered qualitative characterization, the panel turns to a different challenge: what changes when the goal shifts to quantifying a main component or impurity rather than simply identifying it. Piotr Alvarez opens by stressing a two-sided requirement—analysts must ensure they are neither inadvertently generating an impurity during sample manipulation, nor inadvertently degrading one away and undercounting it. He distinguishes between analyzing a drug substance, which typically involves a straightforward active pharmaceutical ingredient (API) dilution, and a drug product, which introduces far more variables: injectable formulations, solid forms, and different delivery vehicles all require different approaches, and excipients can meaningfully affect both separation and recovery. Sustained-release formulations, in which the GLP-1 peptide is embedded in polymeric particles, add another layer of complexity to sample preparation and recovery optimization.

Alvarez also outlines practical stability-testing strategies: comparing a sample's analytical solution at time zero against later time points (such as six or eight hours) under varying temperatures to understand degradation in the autosampler, and running an analogous comparison for on-column degradation by holding analytes at the head of the column before starting the separation. He notes this approach reveals not only new impurities forming but also existing small peaks disappearing as they degrade further—a detail he says is easy to overlook.

Nitish Sharma closes the segment with a specific reproducibility risk: oxidation of methionine residues, which can behave inconsistently across replicate analyses. He cites his own lab's experience with rhPTH 1-34, where methionine oxidation produced meaningful impurity variability, undermining reproducibility in quantitative work. His recommended mitigations include bio-inert high performance liquid chromatography (HPLC) systems and flushing strategies using antioxidant additives in the mobile phase or eluent to suppress uneven oxidation during analysis.